South Africa’s vaccination program has been struggling. It got off to a late start, first using AstraZeneca’s jab. But that was stopped over its ineffectiveness against the variant spreading rapidly in the country.
Then South Africa turned to Johnson and Johnson’s vaccine – but paused that rollout due to concerns about side effects.
But with a second wave of infections now behind them – life in South Africa is starting to appear normal – but it may not stay that way.